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A Forum for Discourse
One of the specific goals of Cell Stem Cell is to provide our readership with a scholarly, published platform on which to
exchange ideas and interpretations of a range of issues relevant to the diverse field of stem cell research. In this issue, we
launch our newest format, called ‘‘Letter,’’ which will become the preferred venue for some items that had previously been
presented as Correspondence articles. In this instance, the discussion point raised is related to a meta-analysis study pub-
lished in our June issue (Levine; 2: 521), comparing the relative contribution of individual nations to the published literature
related to hESC research. In their Letter, Lo¨ser and colleagues discuss their views on the methodology used in the original
study, and an accompanying response Letter from Levine appears alongside their critique. A second new format in this issue
is the ISSCR Annual Report. This feature comprises six short articles that together present a summary of the Society’s prog-
ress and vision. Overall, we hope that CSC continues to develop as a venue for responsible, scholarly discourse on matters
that are relevant to stem cell scientists and related professionals.
Informing Potential Regeneration Methods
The capacity to generate artificial organs from organic, biological building blocks remains a far-off
aim of the field of regenerative medicine. In this issue, McMahon and colleagues take an important
early step in this process by resolving the identity of a multipotent kidney progenitor population by
careful, chronological fate-mapping studies using a series of transgenic murine models. Meanwhile,
Se´guin et al. indicate that SOX7 overexpression in hESC lines results in stable generation of endo-
derm progenitors, and thus yield an additional set of tools to help establish efficient methods to direct
the differentiation of multiple endoderm lineages. Noncellular tools will also be important in the
pursuit of artificial organ formation. Nanotechnologies refer to a broad field of acellular materials
that may be used for providing scaffolds for differentiating progenitors, for labeling and tracking cells
in vivo and in vitro, and for gene and/or protein delivery to target populations. Langer and colleagues
review some of the recent applications of nanomedicine to the stem cell field and specifically
highlight the toxicities that must be taken into account when such tools are put to use.
Keeping Tabs on Induced and Cancer Stem Cells
The rocketing pace of advances that improve the efficiency of defined factor induction of pluripotency in somatic cells
continues to accelerate, with novel publications appearing on an almost weekly basis. This issue of Cell Stem Cell is no
exception; a short Correspondence paper from Jaenisch and colleagues reveals that iPSC generation can be made more
efficient with exposure to Wnt-conditioned media. In a preview article, Takashi Tada provides a short synthesis of this and
several other recent studies, including one from Ding and associates in our June issue (2: 525). Although on a distinct subject,
another synthesis-style article in this issue covers a similarly fast-paced segment of the stem cell field. In their Meeting Report,
Kim and Dirks overview the salient discussion points raised at a recent UCSF symposium focused on Stem Cells and Cancer.
Also a young field within the broader stem cell discipline, the amassing literature on and interest in cancer stem cells can
sometimes seem overwhelming. By providing synthesis perspectives from insightful authors in each field, we aim to help
readers keep pace with the recent advances and sometimes debated interpretations that accompany new findings.
Balances in Bone, Blood, and Beyond
Multiple tumor suppressors have long been known to participate in normal HSC function, although the mechanisms behind
their regulatory control seem as varied as the individual factors in question. In a Short Article in this issue, Scadden and
colleagues reveal that Nf2 (also known as Merlin) is required to maintain a balanced HSC
population and to retain these cells within the bone marrow. Interestingly, Merlin exerts its
effect indirectly, in that loss of the tumor suppressor only impacts HSC function when the
deletion occurs outside hematopoietic lineages. On the other side of the coin, loss of the tran-
scription factor Evi-1 within HSCs leads to hematopoietic failure in both embryonic and adult
compartments, as Kurokawa and associates reveal. Importantly, disruption of the same
gene in transformed leukemic cells also blocks their growth, which thus suggests that the
pathway may offer a therapeutic target if healthy HSCs could be preserved.
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